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Abstract. The potential for inferring the presence of cancer by the de-
tection of miRNA in human blood has motivated research into the design
and operation of DNA-based chemical amplifiers that can operate in bod-
ily fluids. As a first step toward this goal, we have tested the operation of
a DNA-based autocatalytic network in human serum and mouse serum.
With the addition of sodium dodecyl sulfate to prevent degradation by
nuclease activity, the network was found to operate successfully with
both DNA and RNA catalysts.
1 Introduction
Worldwide, approximately 1.3 million deaths per year are caused by lung cancer
[1]. Early detection and diagnosis of cancer can lead to decreased mortality rates,
yet current screening methods require significant resources [2]. Recently, micro-
ribonucleic acids (miRNAs) have been detected in human blood serum [3]. Micro-
RNAs are small, single-stranded, non-coding RNAs that are 21-23 nucleotides
in length and regulate genes by suppression of messenger RNAs [4, 5]. Several
miRNAs are amplified in various cancers [6], and expression profiling reveals
that miRNA signatures can be used for cancer classification and prognosis.
Current diagnosis technology requires reverse-transcription polymerase chain
reaction (RT-PCR) to detect miRNAs in serum [7]. Developments in DNA com-
puting have shown that it is possible to construct metastable DNA-based chem-
ical networks that accept DNA as catalytic inputs and generate output DNA
strands whose concentration increases exponentially to produce an easily de-
tectable signal [8]. As miRNAs occur in blood in low abundance, such ampli-
fication networks would allow for detection without using PCR. In this study,
we report the operation of the DNA-based autocatalytic network reported by
Zhang et al. in human blood serum with sodium dodecyl sulfate (SDS). The au-
tocatalytic DNA system accepts the input of either DNA or RNA catalysts and
produces output signal strands that generate an easily detectable fluorescence
signal.
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2 Autocatalytic Network
To assess the feasibility of detecting miRNA in human serum using a DNA-based
catalytic network, the entropy-driven autocatalytic system developed by Zhang
et al. was selected as a test network. Figure 1(a) reproduces the autocatalytic
network with the same domain naming convention [8]. In this network, strand
4 2bc is the autocatalyst that initiates signal strand production by toehold-
mediated strand invasion of the substrate complex via the 2b domain. With
an exposed 3¯ domain, the fuel strand displaces two autocatalyst strands by
two strand invasion processes and forms the waste complex. In each cycle, the
amount of autocatalyst strand is doubled, leading to exponential growth of the
signal strand. In Fig. 1(b), the released signal strand reacts with a reporter
complex to displace a tetrachlorofluorescein (TET) labeled strand. An increase
in signal strand concentration is detected by an increase in the TET fluorescence
intensity. Zhang et al. were able to demonstrate exponential behavior of this
autocatalytic network in buffer and in a solution with total mouse liver RNA and
rabbit reticulocyte lysate [8], demonstrating successful operation in a complex
biological environment.
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Fig. 1. The DNA-based autocatalytic network reported by Zhang et al. [8]. In (a)
the autocatalyst initiates the release of the signal strand. The fuel strand displaces
both autocatalysts, producing the waste complex. Both released autocatalysts can then
initiate new cycles. In (b) the reporter complex consists of a dye-quencher pair in the
quenched state. The signal strand from (a) reacts with the reporter complex, displacing
the TET dye labeled strand and producing an increase in fluorescence intensity.
3 Network Operation in Serum
To test the autocatalytic system in human serum, the reported DNA sequences
of the network were purchased without modification from Integrated DNA Tech-
nologies with the same purification processes. Substrate and Reporter complexes
were prepared in 1× phosphate buffered saline (PBS) and filtered by polyacry-
lamide gel electrophoresis to remove excess single-stranded components. Both
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DNA and RNA versions of the Autocatalyst strand were used to initiate the
network.
Whole blood was collected from volunteers and allowed to clot for 30 minutes
at room temperature. The clotted solutions were centrifuged at room tempera-
ture for 10 minutes leaving the serum as the supernatant, which was extracted to
separate vials for storage at -80 ◦C. In order to ensure successful operation of the
autocatalytic network in serum, the use of the ionic detergent sodium dodecyl
sulfate (SDS) added to serum was used as a means to suppress nuclease activ-
ity without disrupting DNA hybridization. SDS is commonly used to denature
proteins, and with 10% SDS, DNA lifetime and hybridization rates in serum are
increased [9]. Figure 2 shows the results for operating the autocatalytic network
in a solution of 50% human serum, 10% SDS and 0.5×PBS with both DNA,
Fig. 2(a), and RNA, Fig. 2(b), catalysts. The data represent the normalized flu-
orescence intensity of TET dye integrated over one minute intervals with every
75th data point marked with a symbol. For the data shown in Fig. 2(a), the
Substrate and Fuel components of the network were present in solution at con-
centrations of 100 nM, while the Reporter was present at 200 nM. The network
was operated with zero added catalyst and with the DNA catalyst added at 10
and 100 nM. The times to half completion for the DNA catalyst were 5.5 min.
at 100 nM, 15.6 min. at 10 nM, and 21.7 min. with no catalyst added. For the
data shown in Fig. 2(b), the Substrate and Fuel components of the network were
present in solution at concentrations of 25 nM, while the Reporter was present at
50 nM. The network was operated with zero added catalyst and with the RNA
catalyst added at 2.5 and 25 nM. For the RNA catalyst, the times to half com-
pletion were 54.7, 82.1, and 101.3 min. for 25, 2.5, and 0 nM, respectively. The
resulting fluorescence versus time data are in qualitative agreement with the
results reported previously [8], exhibiting a similar concentration dependence
and initial exponential intensity increase. Although the times to half completion
for the DNA catalyst are similar to previous results, it should be noted that
here the concentrations of all components is 10 times greater. The longer times
to half completion for the RNA catalyst are expected for the factor of four re-
duction in the component concentrations. It should be noted that operation of
the autocatalytic network without added catalyst indicates a non-zero leak rate
of the system, as observed previously [8]. Methods to reduce this leak rate are
currently being studied.
Initial experiments in detecting cancer-related miRNA will be performed in
mouse models of lung cancer. To verify that the autocatalytic network can serve
as a test system for the detection of miRNA in mouse models, the network was
operated in mouse serum. Figure 3 shows the results for autocatalytic network
operation in a solution of 50% mouse serum, 10% SDS, and 0.5×PBS with RNA
catalyst added at concentrations of 10 and 100 nM, as well as operation with
no added catalyst. The measured times to half completion were 13.6, 37.8, and
47.4 min. for 100, 10, and 0 nM, respectively. These half completion times are
only slightly longer than those for DNA catalysts in human serum at the same
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Fig. 2. Autocatalytic network operation in 50% human serum, 10% SDS and 0.5×PBS
with (a) DNA and (b) RNA catalysts. Both the DNA and RNA catalysts successfully
initiated the autocatalytic network. The observed fluorescence increase and catalyst
concentration dependence are in qualitative agreement with the results for network
operation in buffer as reported previously [8].
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component concentrations, Fig. 2(a), which suggests that test results from mouse
models should be readily applicable to human systems.
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Fig. 3. Autocatalytic network operation in 50% mouse serum, 10% SDS and 0.5×PBS
with 100, 10, and 0 nM of RNA catalysts. Network operation in mouse serum was
successful with times to half completion comparable to operation in human serum
with DNA catalysts.
4 Conclusion
A DNA-based autocatalytic network was successfully operated in 50% human
serum, 10% SDS, 0.5×PBS using both DNA and RNA catalysts. Network oper-
ation was also confirmed in mouse serum using an RNA catalyst. Operation in
serum with 10% SDS was shown to be sufficient to prevent rapid degradation
of the network. Times to half completion were similar to those for operation in
buffer solution, although the strand concentrations were an order of magnitude
higher in the experiments reported here. In all cases, the network exhibited an
apparent exponential increase in fluorescence intensity and clear dependence on
the catalyst concentration. These results clearly support the feasibility of de-
tecting miRNA in human serum and mouse serum using a DNA-based catalytic
network.
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